Simpson Thacher represented the underwriters, Morgan Stanley, Citigroup and AMTD Tiger, in connection with the initial public offering and listing on the New York Stock Exchange of American Depositary Shares (“ADSs”) of Weidai Ltd. (“Weidai”). The offering of 4,500,000 ADSs, representing 4,500,000 Class A ordinary shares, raised a total of US$45 million in gross proceeds before the exercise of underwriters’ overallotment option.
Global law firm White & Case LLP has advised on the largest Kazakhstani initial public offering (IPO) on the London Stock Exchange (LSE) in more than a decade, and the first IPO on the newly established Astana International Exchange (AIX), the stock exchange of the Astana International Financial Centre.
Gide advised the Dealers, Banque Degroof Petercam and Invest Securities, on the Euro PP by Financière Apsys of its EUR 39.2 million due November 2023 combining a EUR 29.2 million bond issue and a EUR 10 million loan. The notes are admitted to trading on Euronext Access Paris.
Gide's team was led by partner Hubert du Vignaux, assisted by senior associate Bastien Raisse and associate Laure Bellenger.
Financière Apsys was assisted by De Pardieu Brocas Maffei.
International law firm Clifford Chance has advised a syndicate of banks consisting of CIFI (lender and arranger), Banco Ciudad de Buenos Aires, Banco Itaú Argentina and Compañía Española de Financiación del Desarrollo COFIDES in connection with the financing of an 18 MW Biomass Plant located in the province of Corrientes, Argentina, using a multijurisdictional team of lawyers coordinated from Madrid and led by José Guardo, head of the Spanish Banking and Finance practice area, and Epifanio Pérez, partner of the Banking and Finance practice ar
Firm Capital Mortgage Investment Corporation (the "Corporation") (TSX: FC) announced that it had closed its previously announced bought deal offering of $25 million aggregate principal amount of 5.50% convertible unsecured subordinated debentures of the Corporation due January 31, 2026. The debentures are listed and posted for trading on the Toronto Stock Exchange under the symbol FC.DB.J.
The offering was underwritten by a syndicate of underwriters that was co-led by TD Securities Inc., CIBC Capital Markets and Scotiabank.
Gowling WLG are pleased to have advised long-standing client GuarantCo in respect of the listing by Quantum Terminals Group (QTG), on the London Stock Exchange. Quantum), a leading energy infrastructure developer in Ghana, has listed its GHS 45 million (USD 10 million) corporate bond, guaranteed by GuarantCo (a member of the Private Infrastructure Development Group (PIDG)), on the London Stock Exchange's International Securities Market - completing a dual listing of the debt security, having previously listed it on the Ghanaian Stock Exchange earlier in the year.
Hogan Lovells has advised Monzo, the UK's digital, mobile-only bank, on its biggest ever crowdfunding round. Monzo has just published a prospectus in connection with a £20 million raise from its existing customers. This follows the close of £85m of funding in October this year from General Catalyst, Accel and existing investors, which Taylor Wessing advised on.
DLA Piper has advised Aareal Bank AG in relation to the arrangement of a five-year €447 million financing for a European hotel portfolio managed by Swedish hotel property company Pandox AB.
The portfolio comprises a total of 14 high-quality hotels in the upper full-service segment, in first-class locations in Austria, Belgium, Germany, and the Netherlands, with a total of approximately 3,600 rooms – including the Crowne Plaza Brussels – Le Palace, the Radisson Blu in Cologne, and the Park Hotel Amsterdam.
AlzeCure Pharma AB (publ) has, prior to its listing on Nasdaq First North Premier, completed a new share issue of approximately SEK 200 million before issue costs.
The new share issue generated strong interest and was heavily oversubscribed. Estimated first day of trading in AlzeCure's share on Nasdaq First North Premier is 28 November 2018.
AlzeCure Pharma is a Swedish pharmaceutical research and development company developing innovative and effective drugs for the treatment of brain disease, with a primary focus on Alzheimer’s disease.
Gide acted as underwriters' counsel in a multi-tranche senior bond issuance of USD 3.75 billion by EDF in the context of its return to the USD 144A/RegS bond market.
Gide has advised an underwriting syndicate of eight banks in connection with a senior bond offering of USD 3.75 billion by EDF, by way of a Rule 144A private placement in September. This issuance enables EDF to further strengthen the structure of its balance sheet, as well as refinance upcoming maturities.
The USD 3.75 billion senior bond offering included three tranches: